| The clinical spectrum of Henoch–Schönlein purpura in children: a single-center study ŞG Karadağ, A Tanatar, HE Sönmez, F Çakmak, A Kıyak, S Yavuz, ... Clinical rheumatology 38, 1707-1714, 2019 | 57 | 2019 |
| Real-life data from the largest pediatric familial Mediterranean fever cohort K Öztürk, T Coşkuner, E Baglan, HE Sönmez, GO Yener, F Çakmak, ... Frontiers in Pediatrics 9, 805919, 2022 | 43 | 2022 |
| Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis … G Otar Yener, A Paç Kısaarslan, K Ulu, E Atalay, F Haşlak, S Özdel, ... Rheumatology International 42 (5), 879-889, 2022 | 40 | 2022 |
| Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis … GO Yener, AP Kısaarslan, K Ulu, E Atalay, F Haşlak, S Özdel, BB Yücel, ... Rheumatology international 42 (5), 879, 2021 | 36 | 2021 |
| Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19 O Koker, FG Demirkan, G Kayaalp, F Cakmak, A Tanatar, SG Karadag, ... Rheumatology international 40 (10), 1613-1623, 2020 | 36 | 2020 |
| Nailfold capillaroscopy: a sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection F Çakmak, A Demirbuga, D Demirkol, S Gümüş, SH Torun, GK Kayaalp, ... Microvascular research 138, 104196, 2021 | 25 | 2021 |
| The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch–Schönlein Purpura ŞG Karadağ, F Çakmak, B Çil, A Tanatar, HE Sönmez, A Kıyak, S Yavuz, ... Postgraduate medicine 133 (3), 272-277, 2021 | 25 | 2021 |
| Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center A Tanatar, HE Sönmez, ŞG Karadağ, F Çakmak, M Çakan, F Demir, ... Rheumatology International 40 (1), 21-27, 2020 | 25 | 2020 |
| Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases Ö Akgün, F Cakmak, V Guliyeva, FG Demirkan, A Tanatar, ... Rheumatology 61 (11), 4482-4490, 2022 | 23 | 2022 |
| Leflunomide treatment in juvenile idiopathic arthritis NA Ayaz, ŞG Karadağ, F Çakmak, M Çakan, A Tanatar, HE Sönmez Rheumatology international 39 (9), 1615-1619, 2019 | 23 | 2019 |
| The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study B Sozeri, K Ulu, U Kaya-Akça, F Haslak, A Pac-Kisaarslan, G Otar-Yener, ... Rheumatology international 42 (3), 469-475, 2022 | 20 | 2022 |
| Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey Ö Akgün, GK Kayaalp, FG Demirkan, F Çakmak, A Tanatar, V Guliyeva, ... Vaccine 40 (12), 1829-1836, 2022 | 17 | 2022 |
| Profile of new referrals to a single pediatric rheumatology center in Turkey ŞG Karadağ, HE Sönmez, A Tanatar, F Çakmak, M Çakan, NA Ayaz Rheumatology international 40 (2), 313-321, 2020 | 14 | 2020 |
| Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: a single-centre experience O Koker, FG Demirkan, F Cakmak, N Aktay Ayaz Modern Rheumatology 33 (1), 187-193, 2023 | 9 | 2023 |
| Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group FG Demirkan, K Ulu, K Öztürk, ŞG Karadağ, S Özdel, HE Sönmez, ... Expert opinion on biological therapy 22 (2), 197-202, 2022 | 8 | 2022 |
| Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an … NA Ayaz, ŞG Karadağ, R Koç, FG Demirkan, F Çakmak, HE Sönmez Rheumatology International 40 (7), 1111-1116, 2020 | 8 | 2020 |
| Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years’ experience of a tertiary pediatric rheumatology center R Koç, HE Sönmez, M Çakan, ŞG Karadağ, A Tanatar, F Çakmak, ... Rheumatology International 40 (5), 771-776, 2020 | 8 | 2020 |
| Rheumatic diseases in Syrian refugee children: a retrospective multicentric study in Turkey ŞG Karadağ, HE Sönmez, F Demir, M Çakan, K Öztürk, A Tanatar, ... Rheumatology International 40 (4), 583-589, 2020 | 8 | 2020 |
| Approach to switching biologics in juvenile idiopathic arthritis: a real-life experience ŞG Karadağ, FG Demirkan, R Koç, F Çakmak, HE Sönmez, N Aktay Ayaz Rheumatology international, 1-7, 2021 | 7 | 2021 |
| PREDICT-crFMF score: a novel model for predicting colchicine resistance in children with familial Mediterranean fever N Aktay Ayaz, FG Demirkan, T Coşkuner, F Demir, A Tanatar, M Çakan, ... Modern Rheumatology 34 (1), 220-225, 2024 | 6 | 2024 |
